Answers are grounded in this paper and cite their sources.
Strongyloidiasis is an important parasitic disease, and characterizing the antigenic properties of parasite-derived proteins and the host immune responses they elicit may contribute to a better understanding of host–parasite immune interactions. The highly conserved 14-3-3 proteins have demonstrated immunogenicity in various parasites; however, the immunological characteristics of the Strongyloides stercoralis 14-3-3 protein (Ss14-3-3) warrant further investigation. This study aimed to systematically characterize the molecular properties and immunogenicity of Ss14-3-3 and investigate the associated host immune responses. The Ss14-3-3 gene was cloned, and recombinant Ss14-3-3 (rSs14-3-3) was expressed and purified using a eukaryotic expression system. Its antigenic characteristics and immunogenicity were evaluated through bioinformatic analysis, patient serum recognition, mouse immunization, and splenic transcriptome sequencing. Ss14-3-3 is a hydrophilic protein comprising 245 amino acids, with 12 predicted B-cell epitopes. Sera from infected patients recognized rSs14-3-3. Immunization with rSs14-3-3 formulated with Freund’s adjuvant induced significantly increased antigen-specific IgG1 and IgG2a responses in mice, which progressively increased during immunization. Transcriptomic analysis identified 36 differentially expressed genes, and enrichment analysis of these genes highlighted heme- and porphyrin-related processes, while gene set enrichment analysis of the ranked transcriptome identified enrichment of gene sets associated with B-cell activation and lymphocyte differentiation. These findings extend the characterization of rSs14-3-3 immunogenicity by demonstrating human serum recognition and immunization-induced antibody responses.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: